Physician

Abraham Goodgold, MD

According to 2025 Medicare claims, Abraham Goodgold, MD (NPI: 1184791980) practices endocrinology in the Newark, NJ market, with the plurality of this provider's patient population coming from Union, NJ. This provider's primary affiliated billing organization is UNION COUNTY HEALTH CARE ASSOCIATES LLC (NPI: 1033271291; TIN: 25-1918025) and primary practice location at 07208-1325. Goodgold is affiliated with the RWJBH Accountable Care, LLC (ACO ID: A1247), participating under the MSSP model.

Goodgold's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 211 traditional Medicare patients, billed 1,730 HCPCS/CPT codes, and received $91,809 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,712 prescription claims across 506 beneficiaries totaling $661,579 in drug costs, led by Januvia (Sitagliptin Phosphate). DME data shows 68 claims. Open Payments data shows 51 records totaling $749. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $167,528 to $91,809. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,465 to $1,252.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	702	3,146	$167,528
2016	534	3,188	$171,475
2017	454	2,437	$101,808
2018	443	1,945	$70,546
2019	366	2,016	$73,866
2020	302	2,584	$54,702
2021	280	1,353	$62,339
2022	240	1,392	$53,843
2023	227	1,696	$85,095
2024	211	1,730	$91,809

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	722	12,879	$881,728
2016	713	12,501	$938,486
2017	699	12,005	$953,234
2018	760	12,034	$947,759
2019	735	10,705	$972,029
2020	650	9,112	$872,469
2021	626	8,382	$856,674
2022	573	7,732	$799,017
2023	539	7,292	$865,012
2024	506	6,712	$661,579

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	199	595	$8,419
2016	244	590	$11,123
2017	133	326	$4,216
2018	90	309	$3,846
2019	75	321	$3,801
2020	56	204	$2,452
2021	47	128	$1,382
2022	19	99	$1,316
2023	16	68	$609
2024	13	68	$681

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	157	371	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	89	196	$65
G0444	Annual depression screening, 5 to 15 minutes	94	94	$21
36415	Insertion of needle into vein for collection of blood sample	136	223	$9
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	105	120	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Januvia	Sitagliptin Phosphate	114	7,230	$132,576
Eliquis	Apixaban	116	5,390	$105,742
Jardiance	Empagliflozin	48	3,334	$64,459
Rybelsus	Semaglutide	25	930	$29,585
Farxiga	Dapagliflozin Propanediol	27	1,290	$23,619

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	13	48	$655
A4259	Lancets, per box of 100	N	N/R	20	$26

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	51	$749	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abraham Goodgold, MD?

Tedicare shows public-source Medicare data for Abraham Goodgold, MD (NPI 1184791980), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abraham Goodgold, MD have ACO affiliation data?

Abraham Goodgold, MD is shown with ACO affiliation data for RWJBH Accountable Care, LLC (MSSP, ACO ID A1247).

What billing organization is linked to Abraham Goodgold, MD?

Abraham Goodgold, MD is linked to UNION COUNTY HEALTH CARE ASSOCIATES LLC (billing NPI 1033271291) in the available physician profile data.

Does Abraham Goodgold, MD have Open Payments data?

Abraham Goodgold, MD has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.